Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective is to compare roniciclib with placebo in addition to background treatment with chemotherapy (either cisplatin + etoposide or carboplatin + etoposide) in terms of progression free survival (PFS) in SCLC patients.
Inclusion criteria
- extensive-stage disease small cell lung cancer (ED SCLC)